Development and Validation of an Innovative Stability Indicating Method Using UVSpectroscopy Techniques for Ritonavir in Bulk Drug and Pharmaceutical Dosage Forms

Pharmaceutical Science-Pharmaceutical Analysis

Authors

  • Gurram Sai Venkata Nagendra Abhay Raj School of Pharmacy, GITAM (Deemed to be University), Gandhinagar Campus, Rushikonda, Visakhapatnam-530045, A.P., INDIA.
  • Sumanta Mondal Associate Professor and NSS Programme Officer (Unit-IX), School of Pharmacy, GITAM (Deemed to be University), Visakhapatnam-530045, Andhra Pradesh, INDIA https://orcid.org/0000-0002-0320-3458
  • Subhadip Chakraborty School of Pharmacy, GITAM (Deemed to be University), Gandhinagar Campus, Rushikonda, Visakhapatnam-530045, A.P., INDIA.
  • Moumita Ghosh School of Pharmacy, GITAM (Deemed to be University), Gandhinagar Campus, Rushikonda, Visakhapatnam-530045, A.P., INDIA.

DOI:

https://doi.org/10.22376/ijlpr.2023.13.6.P154-P169

Keywords:

Ritonavir, Zero Order Spectroscopy, Derivative Spectroscopy, First Order Spectroscopy, Area under the curve spectroscopy, Ritomune,, ICH guidelines

Abstract

Ritonavir is a protease inhibitor used to treat HIV/AIDS. It is seldom employed for its antiviral activity but instead as a booster for other protease inhibitors. Our study's significant objective is to develop a new, simple, accurate, precise, and reproducible UV spectrophotometric approach for investigation by apotheosis to analyze ritonavir. Three alternative simple, accurate, and precise UV spectrophotometric techniques-the, zero-order (method A), first-order (method B), and the area under the curve (method C) spectrophotometric methods have been established for the measurement of ritonavir in bulk and pharmaceutical dosage. The drug was dissolved in ethanol, and then 0.063 M Phosphate buffer solution (pH 7.0), and the observed λmax are 271 nm for the zero-order spectrophotometric method (method A), 258 nm for the first-order spectrophotometric method, 260–281 nm for the area under the curve spectrophotometric method (method C). Under the optimum conditions, linear relationships with good correlation coefficients 0.9994–0.9999 were found between the reading and the corresponding concentration of the drug in the range of 10-50 μg/ml. The proposed methods can detect the analyte in the lower limits of 0.24 to 0.38 μg/ml. The precision of the methods was satisfactory, and the percentage relative standard deviation values did not exceed 2%. The proposed methods were successfully applied to the analysis of ritonavir in its bulk and commercial formulations with good repeatability and reproducibility; the label claim percentages ranged from 99.56 to 99.64 ± (0.34-0.63) % w/v. The research findings of the current approach were shown to be more accurate and trustworthy for ritonavir in pharmaceutical dosage forms and bulk pharmaceuticals compared to those previously reported by the spectrophotometric approaches. The proposed techniques can be used for routine inspections without causing any interference from excipients or other substances because of the quick and repeatable analysis.

References

Tegeli V, Birajdar A, Matole V. UV spectrophotometric method development and validation of Darunavir in bulk and solid dosage form. Res J Pharm Technol. 2021;14(6):3262-4. doi: 10.52711/0974-360X.2021.00567.

Sawale VS, Umamaheshwari D. A review on novel analytical techniques used in method development and validation of pharmaceuticals. J Pharm Sci Res. 2020;12(2):321-8.

Ravisankar P, Navya CN, Pravallika D, Sri DN. A review of step-by-step analytical method validation. IOSR J Pharm. 2015;5(10):7-19.

Pradhan KK, Mishra US, Pattnaik S, Panda CK, Sahu KC. Development and validation of a stability-indicating UV spectroscopic method for candesartan in bulk and formulations. Indian J Pharm Sci. 2011;73(6):693-6. doi: 10.4103/0250-474X.100254, PMID 23112408.

Barry M, Mulcahy F, Back DJ. Antiretroviral therapy for patients with HIV disease. Br J Clin Pharmacol. 1998;45(3):221-8. doi: 10.1046/j.1365-2125.1998.00673.x, PMID 9517365.

Hsu A, Granneman GR, Bertz RJ. Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents. Clin Pharmacokinet. 1998;35(4):275-91. doi: 10.2165/00003088-199835040-00002, PMID 9812178.

Kumar KV, Sudhakar M, Reddy YP, Malleshwari P, Hafeez SK. RP-HPLC method development and validation for simultaneous estimation of lopinavir and ritonavir in dosage form and plasma. Int J Pharm Res Rev. 2014;3(9):1-8.

Meini S, Pagotto A, Longo B, Vendramin I, Pecori D, Tascini C. Role of lopinavir/ritonavir in treating Covid-19: a review of current evidence, guideline recommendations, and perspectives. J Clin Med. 2020;9(7):1-13. doi: 10.3390/jcm9072050, PMID 32629768.

Foisy MM, Yakiwchuk EM, Hughes CA. Induction effects of ritonavir: implications for drug interactions. Ann Pharmacother. 2008;42(7):1048-59. doi: 10.1345/aph.1K615, PMID 18577765.

Hsu A, Granneman GR, Cao G, Carothers L, Japour A, El-Shourbagy T et al. Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers. Antimicrob Agents Chemother. 1998;42(11):2784-91. doi 10.1128/AAC.42.11.2784, PMID 9797204.

Lea AP, Faulds D. Ritonavir. Drugs. 1996;52(4):541-6; discussion 547. doi: 10.2165/00003495-199652040-00007, PMID 8891466.

Ponnilavarasan I, Rajasekaran A, Dharuman JG, Kalaiyarasi D, Krishnakumar D. Development and validation of spectrophotometric method for the estimation of lopinavir and ritonavir in tablet dosage form. Asian J Res Chem. 2010;3(1):188-91.

Devineni J, Rangani V, Nunna S. New Sensitive UV- spectrophotometric method for simultaneous estimating lopinavir and ritonavir in fixed-dose combination as soft gels. Int J Pharm Sci Res. 2016;7(1):25-30.

Mondal S, Prathyusha VS, Mondal P, Reddy GS. Development and validation of various UV spectrophotometric methods for estimating famciclovir in bulk and its formulation. Saudi J PharmSci. 2018;4(2):238-48.

Subhadip C, Nalanda RB, Pridhvi KG, Suraj M, Shyamdeo KT. A new second-derivative spectrophotometric method for determining vildagliptin in the pharmaceutical dosage form. Int J Res Pharm Sci. 2021;12(4):2610-4.

Yekkala RS, Ashenafi D, Mariën I, Xin H, Haghedooren E, Hoogmartens J et al. Evaluation of an international pharmacopeia method for analyzing ritonavir by liquid chromatography. J Pharm Biomed Anal. 2008;48(3):1050-4. doi: 10.1016/j.jpba.2008.08.007, PMID 18801634.

Albert V, Modamio P, Cecilia FL, Eduardo LM. Determination of saquinavir and ritonavir in human plasma by RP-HPLC and the analytical error function. J Pharm Biomed Anal. 2004;36(4):835-40.

Usami Y, Oki T, Nakai M, Sagisaka M, Kaneda T. A simple HPLC method for simultaneous determination of lopinavir, ritonavir and efavirenz. Chem Pharm Bull. 2003;51(6):715-8. doi: 10.1248/cpb.51.715.

Richard M, Hoetelmans W, Essenberg MV, Profijt M, Meenhorst PL, Mulder JW. High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid, and saliva. J Chromatogr B Biomed Appl. 1998;705(1):119-26.

Dias CL, Rossi RC, Donato EM, Bergold AM, Fröehlich PE. LC Determination of ritonavir, an HIV protease inhibitor, in soft gelatin capsules. Chroma. 2005;62(11-12):589-93. doi: 10.1365/s10337-005-0670-0.

Proust V, Toth K, Hulin A, Taburet AM, Gimenez F, Singlas E. Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents’ amprenavir, nelfinavir, ritonavir saquinavir, delavirdine and efavirenz in human plasma. J Chromatogr B Biomed Sci Appl. 2000;742(2):453-8. doi: 10.1016/s0378-4347(00)00208-5, PMID 10901152.

Rebiere H, Mazel B, Civade C, Bonnet P. Determination of 19 antiretroviral agents in pharmaceuticals or suspected products with two methods using high-performance liquid chromatography. J Chromatogr B. 2007;850(1-2):376-83. doi: 10.1016/j.jchromb.2006.12.007.

Jagadeeswaran M, Gopal N, Kumar PK, Kumar ST. Quantitative estimation of lopinavir and ritonavir in tablets by RP-HPLC method. Pharm Anal Acta. 2012;3(5):21-4.

Kumar KV, Sudhakar M, Reddy YP, Malleshwari P, Hafeez SK. RP-HPLC method development and validation for simultaneous estimation of lopinavir and ritonavir in dosage form and in plasma. Int J Pharm Sci Rev Res. 2014;3(9):1-8.

United States pharmacopeia. The United States of America Pharmacopeial Convention. Vol. 3669. US Pharmacopeia 42; 2019; II. p. NF37.

Anonymous. Validation of analytical procedures: methodology. International Conference on Harmonization. Vol. Q2B; 2005.

Anonymous. Text on validation of analytical procedures. International Conference on Harmonization (ICH). Geneva, Switzerland. 2005; Q2. Vol. R1.

Ali SNS, Mobina L, Mehfuza M, Seema P, Ahmed A, Khan GJ. Analytical method development and validation and forced degradation stability-indicating studies of favipiravir by RP-HPLC and UV in bulk and pharmaceutical dosage form. J Pharm Res Int. 2021;33(48B):254-71. doi: 10.9734/jpri/2021/v33i48B33283.

Mondal S, Pal A, Mondal P, Shit D, Biswal S, Mohan Babu BM. Determination of irbesartan using stability indicating reverse phase liquid chromatographic and UV spectrophotometric Method. Int J Pharm Investig. 2020;10(1):70-5. doi: 10.5530/ijpi.2020.1.13.

Surwade P, Shelke A, Bendale AR, Borse L, Jadhav AG. Method stability indicating method development and validation for emitricitabine by UV spectroscopic and RP-HPLC methods. Int J Pharm Chem Anal. 2022;9(1):10-6.

Shinde G, Godage RK, Jadhav RS, Manoj B, Aniket B. A review on advances in UV spectroscopy. Res J Sci Technol. 2020;12(1):47-51. doi: 10.5958/2349-2988.2020.00005.4.

Blessy M, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation and stability indicating studies of drugs-A review. J Pharm Anal. 2014;4(3):159-65. doi: 10.1016/j.jpha.2013.09.003, PMID 29403878.

Chakraborty S, Mondal S. A Green Eco-friendly Analytical Method Development, Validation, and Stress Degradation Studies of favipiravir in Bulk and Different Tablet Dosages form by UV-spectrophotometric and RP-HPLC Methods with their Comparison by using ANOVA and in-vitro Dissolution Studies. Int J Pharm Investigation. 2023;13(2):290-305. doi: 10.5530/ijpi.13.2.039.

Ghosh M, Mondal S, Chakraborty S, Ghosh N. A stability-indicating method was developed and validated for the estimation of carbamazepine in bulk and tablet dosage form by UV-spectroscopic techniques. J Drug Deliv Ther. 2023;13(3):85-104. doi: 10.22270/jddt.v13i3.5987.

Chakraborty S, Mondal S. A systematic and concise review on the development of analytical and bioanalytical methods for the simultaneous estimation of abacavir sulfate and lamivudine. Ymer. 2022;21(12):912-35.

Ramakrishna B, Mondal S, Chakraborty S. Development and validation of a novel method for the determination of favipiravir and peramivir using reverse phase ultraperformance liquid chromatography. Ymer. 2022;21(10):1618-32.

Maneka SL, Saravanakumar RTS, Male A. Stability-indicating method development and validation for simultaneous estimation of ombitasvir, paritaprevir, and ritonavir in formulation by ultraperformance liquid chromatography. Int J Pharm Sci Drug Res. 2022;12(5):457-63. doi: 10.25004/IJPSDR.2020.120505.

Ramakrishna B, Mondal S, Chakraborty S. A new stability indicating method development and validation report for the assay of nivolumab by RP- UPLC. J Pharm Neg Results. 2022;13(7):1020-32.

Sai KJ, Mondal S, Chakraborty S, Revu BN. A Sensitive and economical different spectroscopic methods development and validation for the quantification of capecitabine and stress degradation studies. Int J Appl Pharm. 2023;15(3):90-9. doi: 10.22159/ijap.2023v15i3.47316.

Bysani SB, Mondal S, Chakraborty S, Killari KN. An innovative stability-indicating liquid chromatography with tandem mass spectrometry method development and validation for the determination of sotorasib in human plasma. Indian J Pharm Sci 2023;85(3):789-798. doi: 10.36468/pharmaceutical-sciences.1145.

Published

2023-11-01

How to Cite

Sai Venkata Nagendra Abhay Raj, G., Mondal, S., Chakraborty, S., & Ghosh, M. (2023). Development and Validation of an Innovative Stability Indicating Method Using UVSpectroscopy Techniques for Ritonavir in Bulk Drug and Pharmaceutical Dosage Forms: Pharmaceutical Science-Pharmaceutical Analysis. International Journal of Life Science and Pharma Research, 13(6), P154-P169. https://doi.org/10.22376/ijlpr.2023.13.6.P154-P169

Issue

Section

Research Articles